SRPT

Sarepta Therapeutics Inc (NASDAQ: SRPT) is rocketing in the market today, gaining more than 30% after announcing that the FDA has approved its DMD drug,… Read More »Sarepta Therapeutics (SRPT) Stock Fies On FDA Approval